The third quarter of 2023 was another mixed bag for major insurers as they continue to grapple with significant headwinds. | ...
Health insurance companies are counting on specialty pharmacy to invigorate their finances as other business lines face headwinds.
The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
President Donald Trump has won back the White House, and with his win, many health plans are seeing their stocks rise. | ...
UnitedHealth Group Inc. shares rose as much as 9.3% before U.S. markets opened, while shares of Humana Inc. gained as much as ...
Three independent pharmacies have filed separate lawsuits accusing GoodRx, which markets a prescription drug discount card, of conspiring with several pharmacy benefit managers to fix ...
New clinical trial data show there is no benefit to waiting when it comes to heart-valve replacement surgery. Other news includes: Ozempic and Wegovy now available, after long shortage; AirPods Pro ...
Baxter covers the Healthcare sector, focusing on stocks such as Humana, CVS Health, and Centene. Cigna has an analyst consensus of Strong Buy, with a price target consensus of $400.11. CI market ...
CVS Health Corp (NYSE:CVS) reported third-quarter sales of $95.43 billion, beating the consensus of $92.75 billion. Total ...